Insiders and friends have invested many millions of dollars in the last few years in Zenith and RVX. Most of the funds were invested in Zenith. But they keep funnelling cash from Zenith into RVX. Why would they do that if they don't think it's worth it? And why would HL extend the debenture for 2 additional years? And they don't have a board member in RVX. And other major investors in both companies seem to be standing pat. IMO, something has got to be cooking.

Other than that it's just a gut feeling and by all indications, good science in apabetalone and ZEN-3694 and other potentials we don't know much about.    

Glass half full ... Koo